Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00003128Phase 3Completed
A Phase 3 trial of paclitaxel in uterine carcinosarcoma (UCS), sponsored by GOG Foundation. Started Nov 1997; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00003128.